Colorectal cancer, which affects the colon or rectum, has long been considered a disease mostly seen in older adults. But in recent years, doctors have noticed a troubling shift: more and more young people under the age of 50 are being diagnosed with this type of cancer. This rising trend has puzzled scientists and led to urgent efforts to uncover the reasons behind it.
A new study published in eBioMedicine has provided an important clue. Researchers have discovered that the bacteria found in tumors from younger colorectal cancer patients are different from those in older patients. This finding could lead to new ways of detecting, understanding, and even treating the disease in young adults.
The study was led by Dr. Alok Khorana, an oncologist at the Cleveland Clinic. Using advanced gene sequencing tools, his team looked at tissue samples from people with colorectal cancer. They compared samples from younger patients to those from older individuals and found key differences in the types and amounts of bacteria present in the tumors.
Not only were there more bacteria in the tumors from younger patients, but certain bacteria—like Akkermansia and Bacteroides—were also more common. These bacteria may play a role in how the cancer develops or progresses in younger individuals.
Why does this matter? Colorectal cancer is now one of the leading causes of cancer deaths among people under 50 in the United States. According to the American Cancer Society, both the number of new cases and deaths from colorectal cancer in young people are going up every year.
Even more concerning, experts predict that by the year 2030, the number of colon cancer cases in people under 50 could double, and rectal cancer cases could quadruple.
These new findings offer hope that we may soon have better tools to fight this growing health problem. If certain bacteria are linked to colorectal cancer in younger people, they could serve as early warning signs—something doctors could look for in stool samples or other tests. This might allow for earlier diagnosis, when the cancer is easier to treat.
The researchers behind the study, including Dr. Shimoli Barot and Dr. Naseer Sangwan, also see the potential for new treatments that target the harmful bacteria. If we can understand how these microbes are affecting the body, we might be able to create therapies that block their influence or restore a healthier balance of bacteria in the gut.
Still, the scientists caution that more research is needed. Many factors could be driving the rise in young-onset colorectal cancer, including lifestyle habits like poor diet, obesity, and certain medications. All of these can affect gut health and might explain why some people are at greater risk.
This research is an important step in a larger effort to understand why colorectal cancer is striking more young people—and what can be done about it. It also adds to a growing body of evidence showing just how important gut bacteria are to our overall health.
If you’re concerned about cancer risk, other studies have found that regular exercise may help prevent cancer, and that vitamin D may reduce the risk of dying from the disease. There’s also evidence that a diet rich in yogurt and fiber could lower the risk of lung cancer, and that new treatments may help the immune system fight cancer more effectively.
As scientists continue to study the link between gut bacteria and cancer, this knowledge may lead to life-saving changes in how we screen for and treat cancers—especially in younger people who may not yet think they’re at risk.
If you care about inflammation, please read studies about the big cause of inflammation in common bowel disease, and vitamin B may help fight COVID-19 and reduce inflammation.
For more health information, please see recent studies about new way to halt excessive inflammation, and results showing foods that could cause inflammation.
Copyright © 2025 Knowridge Science Report. All rights reserved.
